What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2024-04-10 compared with 2023-03-28 · 24 added, 35 removed, 3 unchanged (95% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity

common stock is quoted on The Nasdaq Stock Market LLC under the symbol “KITT.” Our redeemable warrants are quoted on The

Nasdaq Stock Market LLC under the symbol “KITTW.”

of the date of this report, there are approximately 38 shareholders of record of our common stock based upon our transfer agent’s

Because many of our shares of common stock are held by brokers and other nominees on behalf of shareholders, including in trust,

we are unable to estimate the total number of shareholders represented by these record holders.

have not declared or paid any cash dividends on our common stock.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common stock is quoted on The Nasdaq Capital Market under the symbol “KITT.” Our redeemable warrants are quoted on The Nasdaq Capital Market under the symbol “KITTW.”

As of the date of this report, there are approximately 37 shareholders of record of our common stock based upon our transfer agent’s report.

Because many of our shares of common stock are held by brokers and other nominees on behalf of shareholders, including in trust, we are unable to estimate the total number of shareholders represented by these record holders.

We have not declared or paid any cash dividends on our common stock.

To date we have utilized all available cash to finance our operations.

Payment of cash dividends in the future will be at the discretion of our Board and will depend upon our earnings levels, capital requirements,

any restrictive loan covenants and other factors the Board considers relevant.

December 31, 2022, there were 18,722,425 warrants outstanding, including the SPA Warrants, for the purchase of Company common stock.

Refer to Note 10 to the consolidated financial statements included in this annual report for additional information relating to outstanding

Compensation Plans

September 6, 2022, shareholders approved our 2022 Omnibus Incentive Plan (the “Omnibus Incentive Plan”) and on September

9, 2022, our Board ratified the Omnibus Incentive Plan.

The Omnibus Incentive Plan provides for the grant of options, stock appreciation

rights, RSUs, restricted stock and other stock-based awards, any of which may be performance-based, and for incentive bonuses, which

may be paid in cash, Common Stock or a combination thereof.

At December 31, 2022, 4,589,777 equity units were available for future issuance

under the Omnibus Incentive Plan.

the Closing Date of the Business Combination, Nauticus Robotics Holdings had 279,464 options outstanding for the purchase of its common

Payment of cash dividends in the future will be at the discretion of our Board and will depend upon our earnings levels, capital requirements, any restrictive loan covenants and other factors the Board considers relevant.

At December 31, 2023, there were 43,524,241 warrants outstanding, including the SPA Warrants, for the purchase of Company common stock.

Refer to Note 12 to the consolidated financial statements included in this annual report for additional information relating to outstanding warrants.

Equity Compensation Plans

On September 6, 2022, shareholders approved our 2022 Omnibus Incentive Plan (the “Omnibus Incentive Plan”) and on September 9, 2022, our Board ratified the Omnibus Incentive Plan.

The Omnibus Incentive Plan provides for the grant of options, stock appreciation rights, RSUs, restricted stock and other stock-based awards, any of which may be performance-based, and for incentive bonuses, which may be paid in cash, Common Stock or a combination thereof.

At December 31, 2023, 7,651,662 equity units were available for future grants under the Omnibus Incentive Plan.

At the Closing Date of the Business Combination, Nauticus Robotics Holdings had 279,464 options outstanding for the purchase of its common stock.

The outstanding options were converted into 3,970,266 options to purchase shares of our Common Stock.

Outstanding options vest

assuming continuous service to the Company with 25% of the options vesting one year after grant and the balance vesting in a series of

36 successive equal monthly installments measured from the first anniversary of the grant.

During the vesting period, holders have no

rights of a stockholder with respect to the shares of Common Stock subject to an option and the options may not be sold, assigned, transferred,

pledged, or otherwise encumbered.

Outstanding options vest assuming continuous service to the Company with 25% of the options vesting one year after grant and the balance vesting in a series of 36 successive equal monthly installments measured from the first anniversary of the grant.

During the vesting period, holders have no rights of a stockholder with respect to the shares of Common Stock subject to an option and the options may not be sold, assigned, transferred, pledged, or otherwise encumbered.

Unvested options are forfeited upon termination of employment.

December 31, 2022, there were 3,506,184 options outstanding for the purchase of Company common stock.

Refer to Note 11 to the consolidated

financial statements included in this annual report for additional information relating to outstanding options.

December 31, 2022, there were 3,134,677 restricted stock units outstanding for the right to receive one share of Company common stock.

Refer to Note 11 to the consolidated financial statements included in this annual report for additional information relating to restricted

Sales of Unregistered Securities

made no sales of our equity securities within the fourth quarter of the fiscal year covered by the report.

of Equity Securities by the Issuer and Affiliated Purchasers

made no purchases of our equity securities within the fourth quarter of the fiscal year covered by the report.

At December 31, 2023, there were 3,011,247 options outstanding for the purchase of Company common stock.

Refer to Note 13 to the consolidated financial statements included in this annual report for additional information relating to outstanding options.

At December 31, 2023, there were 2,371,973 restricted stock units outstanding for the right to receive one share of Company common stock.

Refer to Note 13 to the consolidated financial statements included in this annual report for additional information relating to restricted stock units.

Recent Sales of Unregistered Securities

We sold $700,000 of our equity securities within the fourth quarter of the fiscal year covered by the report.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

We made no purchases of our equity securities within the fourth quarter of the fiscal year covered by the report.

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity